通过IGF2BP3识别的N6-甲基亚诺辛修饰的SRD5A3,在膀癌中维持了对西斯的耐药性

Kai Liao1, Jing Li2, Caixian He3

  • 1Department of Radiotherapy, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, No. 78 Hengzhigang, Yuexiu District, Guangzhou, 510095, China. coolio620@163.com.

Human cell
|December 16, 2024
PubMed
概括

这项研究揭示了N6-甲基氨酸 (m6A) 修饰,特别是涉及IGF2BP3和SRD5A3,如何在膀癌中驱动西斯普拉丁耐药性. 针对这种途径为膀癌患者提供了潜在的新疗法.